{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T13:07:20Z","timestamp":1789132040487,"version":"build-2803163510"},"reference-count":50,"publisher":"Springer Science and Business Media LLC","license":[{"start":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T00:00:00Z","timestamp":1789084800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T00:00:00Z","timestamp":1789084800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Updates Surg"],"DOI":"10.1007\/s13304-026-02839-9","type":"journal-article","created":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T12:18:29Z","timestamp":1789129109000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Risk factors for complications after cytoreductive surgery (CRS) and HIPEC in 290 peritoneal malignancies of primary and secondary origins"],"prefix":"10.1007","author":[{"given":"Ludovico","family":"Carbone","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gianmario Edoardo","family":"Poto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aurora","family":"Visani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Riccardo","family":"Mainenti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marta","family":"Fasulo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eleonora","family":"Andreucci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Engjell","family":"Kelmendi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefania","family":"Piccioni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Irene","family":"Crecchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giovanna","family":"Gallucci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lucia","family":"Bobbio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhouqiao","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Salvatora Tindara","family":"Miano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roberto","family":"Petrioli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Franco","family":"Roviello","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2066-1618","authenticated-orcid":false,"given":"Daniele","family":"Marrelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,9,11]]},"reference":[{"key":"2839_CR1","doi-asserted-by":"publisher","DOI":"10.1038\/s41572-021-00326-6","volume":"7","author":"D Cort\u00e9s-Guiral","year":"2021","unstructured":"Cort\u00e9s-Guiral D, H\u00fcbner M, Alyami M et al (2021) Primary and metastatic peritoneal surface malignancies. Nat Rev Dis Primers 7:91. https:\/\/doi.org\/10.1038\/s41572-021-00326-6","journal-title":"Nat Rev Dis Primers"},{"key":"2839_CR2","doi-asserted-by":"publisher","first-page":"2838","DOI":"10.1007\/s12094-024-03837-2","volume":"27","author":"L Carbone","year":"2025","unstructured":"Carbone L, Incognito GG, Incognito D et al (2025) Clinical implications of epithelial-to-mesenchymal transition in cancers which potentially spread to peritoneum. Clin Transl Oncol 27:2838\u20132851. https:\/\/doi.org\/10.1007\/s12094-024-03837-2","journal-title":"Clin Transl Oncol"},{"key":"2839_CR3","doi-asserted-by":"publisher","first-page":"1190","DOI":"10.1002\/jso.70090","volume":"132","author":"M Patel","year":"2025","unstructured":"Patel M, Limbach K, Martin E et al (2025) Peritoneal metastases in gastrointestinal malignancies: a review of the pathophysiology of metastasis and the tumour microenvironment. J Surg Oncol 132:1190\u20131196. https:\/\/doi.org\/10.1002\/jso.70090","journal-title":"J Surg Oncol"},{"key":"2839_CR4","doi-asserted-by":"publisher","DOI":"10.1016\/j.omton.2024.200767","volume":"32","author":"A Sikora","year":"2024","unstructured":"Sikora A, Sullivan KM, Dineen S et al (2024) Emerging therapeutic approaches for peritoneal metastases from gastrointestinal cancers. Mol Ther Oncol 32:200767. https:\/\/doi.org\/10.1016\/j.omton.2024.200767","journal-title":"Mol Ther Oncol"},{"key":"2839_CR5","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1097\/00000658-199501000-00004","volume":"221","author":"PH Sugarbaker","year":"1995","unstructured":"Sugarbaker PH (1995) Peritonectomy procedures. Ann Surg 221:29\u201342. https:\/\/doi.org\/10.1097\/00000658-199501000-00004","journal-title":"Ann Surg"},{"key":"2839_CR6","doi-asserted-by":"publisher","first-page":"7954","DOI":"10.3748\/wjg.v21.i26.7954","volume":"21","author":"D Marrelli","year":"2015","unstructured":"Marrelli D (2015) Multimodal treatment of gastric cancer in the west: where are we going? World J Gastroenterol 21:7954. https:\/\/doi.org\/10.3748\/wjg.v21.i26.7954","journal-title":"World J Gastroenterol"},{"key":"2839_CR7","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1002\/jso.24813","volume":"117","author":"WF Morano","year":"2018","unstructured":"Morano WF, Khalili M, Chi DS et al (2018) Clinical studies in CRS and HIPEC: trials, tribulations, and future directions\u2014a systematic review. J Surg Oncol 117:245\u2013259. https:\/\/doi.org\/10.1002\/jso.24813","journal-title":"J Surg Oncol"},{"key":"2839_CR8","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejso.2023.07.002","volume":"49","author":"PH Sugarbaker","year":"2023","unstructured":"Sugarbaker PH (2023) A narrative review of what can HIPEC do. Eur J Surg Oncol 49:106976. https:\/\/doi.org\/10.1016\/j.ejso.2023.07.002","journal-title":"Eur J Surg Oncol"},{"key":"2839_CR9","doi-asserted-by":"publisher","DOI":"10.3390\/cancers15123137","volume":"15","author":"P Sammartino","year":"2023","unstructured":"Sammartino P, De Manzoni G, Marano L et al (2023) Gastric cancer (GC) with peritoneal metastases (PMs): an overview of Italian PSM Oncoteam evidence and study purposes. Cancers (Basel) 15:3137. https:\/\/doi.org\/10.3390\/cancers15123137","journal-title":"Cancers (Basel)"},{"key":"2839_CR10","doi-asserted-by":"publisher","DOI":"10.3390\/cancers14236010","volume":"14","author":"D Marrelli","year":"2022","unstructured":"Marrelli D, Ansaloni L, Federici O et al (2022) Cytoreductive surgery (CRS) and HIPEC for advanced ovarian cancer with peritoneal metastases: Italian PSM Oncoteam evidence and study purposes. Cancers (Basel) 14:6010. https:\/\/doi.org\/10.3390\/cancers14236010","journal-title":"Cancers (Basel)"},{"key":"2839_CR11","doi-asserted-by":"publisher","DOI":"10.3390\/cancers15030728","volume":"15","author":"M Vaira","year":"2023","unstructured":"Vaira M, Robella M, Guaglio M et al (2023) Diagnostic and therapeutic algorithm for appendiceal tumors and pseudomyxoma peritonei: a consensus of the Peritoneal Malignancies Oncoteam of the Italian Society of Surgical Oncology (SICO). Cancers (Basel) 15:728. https:\/\/doi.org\/10.3390\/cancers15030728","journal-title":"Cancers (Basel)"},{"key":"2839_CR12","doi-asserted-by":"publisher","DOI":"10.3390\/cancers15030662","volume":"15","author":"S Kusamura","year":"2023","unstructured":"Kusamura S, Baratti D, De Simone M et al (2023) Diagnostic and therapeutic pathway in diffuse malignant peritoneal mesothelioma. Cancers (Basel) 15:662. https:\/\/doi.org\/10.3390\/cancers15030662","journal-title":"Cancers (Basel)"},{"key":"2839_CR13","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1001\/jamasurg.2013.3640","volume":"149","author":"MD Jafari","year":"2014","unstructured":"Jafari MD, Halabi WJ, Stamos MJ et al (2014) Surgical outcomes of hyperthermic intraperitoneal chemotherapy. JAMA Surg 149:170. https:\/\/doi.org\/10.1001\/jamasurg.2013.3640","journal-title":"JAMA Surg"},{"key":"2839_CR14","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1007\/s13193-016-0504-6","volume":"7","author":"SS Mehta","year":"2016","unstructured":"Mehta SS, Gelli M, Agarwal D, Go\u00e9r\u00e9 D (2016) Complications of cytoreductive surgery and HIPEC in the treatment of peritoneal metastases. Indian J Surg Oncol 7:225\u2013229. https:\/\/doi.org\/10.1007\/s13193-016-0504-6","journal-title":"Indian J Surg Oncol"},{"key":"2839_CR15","doi-asserted-by":"publisher","first-page":"e38","DOI":"10.1016\/j.suronc.2010.09.002","volume":"20","author":"F Roviello","year":"2011","unstructured":"Roviello F, Caruso S, Marrelli D et al (2011) Treatment of peritoneal carcinomatosis with cytoreductive surgery and hyperthermic intraperitoneal chemotherapy: state of the art and future developments. Surg Oncol 20:e38\u2013e54. https:\/\/doi.org\/10.1016\/j.suronc.2010.09.002","journal-title":"Surg Oncol"},{"key":"2839_CR16","doi-asserted-by":"publisher","first-page":"173","DOI":"10.3109\/02656736.2015.1111432","volume":"32","author":"K Polom","year":"2016","unstructured":"Polom K, Marano L, Roviello G et al (2016) Evolution and emerging future of cytoreducxtive surgery and hyperthermic intraperitoneal chemoperfusion in gastric cancer: from treating the incurable to preventing recurrence. Int J Hyperthermia 32:173\u2013179. https:\/\/doi.org\/10.3109\/02656736.2015.1111432","journal-title":"Int J Hyperthermia"},{"key":"2839_CR17","doi-asserted-by":"publisher","DOI":"10.1016\/j.lanepe.2021.100058","volume":"3","author":"T Andr\u00e9","year":"2021","unstructured":"Andr\u00e9 T (2021) Centralized multidisciplinary team assessment of metastasis resectability in patients with metastatic colorectal cancer: a fundamental necessity. Lancet Reg Health Eur 3:100058. https:\/\/doi.org\/10.1016\/j.lanepe.2021.100058","journal-title":"Lancet Reg Health Eur"},{"key":"2839_CR18","doi-asserted-by":"publisher","DOI":"10.3390\/cancers17121938","volume":"17","author":"D Marrelli","year":"2025","unstructured":"Marrelli D, Carbone L, Fusario D et al (2025) Pressurized intra-peritoneal aerosol chemotherapy (PIPAC) for peritoneal malignancies with palliative and bidirectional intent. Cancers (Basel) 17:1938. https:\/\/doi.org\/10.3390\/cancers17121938","journal-title":"Cancers (Basel)"},{"key":"2839_CR19","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejso.2024.107955","volume":"50","author":"E Vachez","year":"2024","unstructured":"Vachez E, Kefleyesus A, Bakrin N et al (2024) Eliminating the need for preoperative intravenous hyperhydration: sodium thiosulfate as nephrotoxicity prevention in HIPEC-treated patients \u2013 a retrospective analysis. Eur J Surg Oncol 50:107955. https:\/\/doi.org\/10.1016\/j.ejso.2024.107955","journal-title":"Eur J Surg Oncol"},{"key":"2839_CR20","doi-asserted-by":"publisher","first-page":"8144","DOI":"10.1245\/s10434-023-14216-6","volume":"30","author":"RN Senguttuvan","year":"2023","unstructured":"Senguttuvan RN, Santiago NL, Han ES et al (2023) Impact of sodium thiosulfate on prevention of nephrotoxicities in HIPEC: an ancillary evaluation of cisplatin-induced toxicities in ovarian cancer. Ann Surg Oncol 30:8144\u20138155. https:\/\/doi.org\/10.1245\/s10434-023-14216-6","journal-title":"Ann Surg Oncol"},{"key":"2839_CR21","doi-asserted-by":"publisher","DOI":"10.1186\/1477-7800-2-3","volume":"2","author":"RL Harmon","year":"2005","unstructured":"Harmon RL, Sugarbaker PH (2005) Prognostic indicators in peritoneal carcinomatosis from gastrointestinal cancer. Int Semin Surg Oncol 2:3. https:\/\/doi.org\/10.1186\/1477-7800-2-3","journal-title":"Int Semin Surg Oncol"},{"key":"2839_CR22","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1007\/s13193-016-0518-0","volume":"7","author":"PH Sugarbaker","year":"2016","unstructured":"Sugarbaker PH (2016) Preoperative assessment of cancer patients with peritoneal metastases for complete cytoreduction. Indian J Surg Oncol 7:295\u2013302. https:\/\/doi.org\/10.1007\/s13193-016-0518-0","journal-title":"Indian J Surg Oncol"},{"key":"2839_CR23","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1016\/S1053-4296(03)00031-6","volume":"13","author":"A Trotti","year":"2003","unstructured":"Trotti A, Colevar A, Setser A et al (2003) CTCAE v3.0: development of a comprehensive grading system for the adverse effects of cancer treatment. Semin Radiat Oncol 13:176\u2013181. https:\/\/doi.org\/10.1016\/S1053-4296(03)00031-6","journal-title":"Semin Radiat Oncol"},{"key":"2839_CR24","doi-asserted-by":"publisher","first-page":"8115","DOI":"10.1245\/s10434-023-13932-3","volume":"30","author":"A Bhatt","year":"2023","unstructured":"Bhatt A, Glehen O, Zivanovic O et al (2023) The 2022 PSOGI international consensus on HIPEC regimens for peritoneal malignancies: epithelial ovarian cancer. Ann Surg Oncol 30:8115\u20138137. https:\/\/doi.org\/10.1245\/s10434-023-13932-3","journal-title":"Ann Surg Oncol"},{"key":"2839_CR25","doi-asserted-by":"publisher","first-page":"4980","DOI":"10.1245\/s10434-020-08843-6","volume":"27","author":"AC Gamboa","year":"2020","unstructured":"Gamboa AC, Lee RM, Turgeon MK et al (2020) Implications of postoperative complications for survival after cytoreductive surgery and HIPEC: a multi-institutional analysis of the US HIPEC collaborative. Ann Surg Oncol 27:4980\u20134995. https:\/\/doi.org\/10.1245\/s10434-020-08843-6","journal-title":"Ann Surg Oncol"},{"key":"2839_CR26","doi-asserted-by":"publisher","first-page":"900","DOI":"10.1097\/SLA.0b013e3181a45d86","volume":"249","author":"TC Chua","year":"2009","unstructured":"Chua TC, Yan TD, Saxena A, Morris DL (2009) Should the treatment of peritoneal carcinomatosis by cytoreductive surgery and hyperthermic intraperitoneal chemotherapy still be regarded as a highly morbid procedure? Ann Surg 249:900\u2013907. https:\/\/doi.org\/10.1097\/SLA.0b013e3181a45d86","journal-title":"Ann Surg"},{"key":"2839_CR27","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1016\/S0140-6736(21)00001-5","volume":"397","author":"GlobalSurg Collaborative","year":"2021","unstructured":"GlobalSurg Collaborative, National Institute for Health Research Global Health Research Unit on Global Surgery (2021) Global variation in postoperative mortality and complications after cancer surgery: a multicentre, prospective cohort study in 82 countries. Lancet 397:387\u2013397. https:\/\/doi.org\/10.1016\/S0140-6736(21)00001-5","journal-title":"Lancet"},{"key":"2839_CR28","doi-asserted-by":"publisher","first-page":"3","DOI":"10.4103\/joacp.JOACP_93_18","volume":"35","author":"N Gupta","year":"2019","unstructured":"Gupta N, Kumar V, Garg R et al (2019) Anesthetic implications in hyperthermic intraperitoneal chemotherapy. J Anaesthesiol Clin Pharmacol 35:3. https:\/\/doi.org\/10.4103\/joacp.JOACP_93_18","journal-title":"J Anaesthesiol Clin Pharmacol"},{"key":"2839_CR29","doi-asserted-by":"publisher","first-page":"875","DOI":"10.3390\/curroncol30010067","volume":"30","author":"L Marano","year":"2023","unstructured":"Marano L, Carbone L, Poto GE et al (2023) Extended lymphadenectomy for gastric cancer in the neoadjuvant era: current status, clinical implications and contentious issues. Curr Oncol 30:875\u2013896. https:\/\/doi.org\/10.3390\/curroncol30010067","journal-title":"Curr Oncol"},{"key":"2839_CR30","doi-asserted-by":"publisher","first-page":"931","DOI":"10.1016\/j.ejso.2013.06.001","volume":"39","author":"S Riss","year":"2013","unstructured":"Riss S, Mohamed F, Dayal S et al (2013) Peritoneal metastases from colorectal cancer: patient selection for cytoreductive surgery and hyperthermic intraperitoneal chemotherapy. European J Surg Oncol (EJSO) 39:931\u2013937. https:\/\/doi.org\/10.1016\/j.ejso.2013.06.001","journal-title":"European J Surg Oncol (EJSO)"},{"key":"2839_CR31","doi-asserted-by":"publisher","first-page":"3284","DOI":"10.1200\/JCO.2004.10.012","volume":"22","author":"O Glehen","year":"2004","unstructured":"Glehen O, Kwiatkowski F, Sugarbaker PH et al (2004) Cytoreductive surgery combined with perioperative intraperitoneal chemotherapy for the management of peritoneal carcinomatosis from colorectal cancer: a multi-institutional study. J Clin Oncol 22:3284\u20133292. https:\/\/doi.org\/10.1200\/JCO.2004.10.012","journal-title":"J Clin Oncol"},{"issue":"1","key":"2839_CR32","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2018.6847","volume":"2","author":"JM Foster","year":"2019","unstructured":"Foster JM, Sleightholm R, Patel A et al (2019) Morbidity and mortality rates following cytoreductive surgery combined with hyperthermic intraperitoneal chemotherapy compared with other high-risk surgical oncology procedures. JAMA Netw Open 2(1):e186847. https:\/\/doi.org\/10.1001\/jamanetworkopen.2018.6847","journal-title":"JAMA Netw Open"},{"key":"2839_CR33","doi-asserted-by":"publisher","first-page":"914","DOI":"10.1245\/s10434-016-5686-1","volume":"24","author":"A Di Giorgio","year":"2017","unstructured":"Di Giorgio A, De Iaco P, De Simone M et al (2017) Cytoreduction (peritonectomy procedures) combined with hyperthermic intraperitoneal chemotherapy (HIPEC) in advanced ovarian cancer: retrospective Italian multicenter observational study of 511 cases. Ann Surg Oncol 24:914\u2013922. https:\/\/doi.org\/10.1245\/s10434-016-5686-1","journal-title":"Ann Surg Oncol"},{"key":"2839_CR34","doi-asserted-by":"publisher","first-page":"858","DOI":"10.1097\/DCR.0000000000000149","volume":"57","author":"D Baratti","year":"2014","unstructured":"Baratti D, Kusamura S, Iusco D et al (2014) Postoperative Complications After Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy Affect Long-term Outcome of Patients With Peritoneal Metastases From Colorectal Cancer. Dis Colon Rectum 57:858\u2013868. https:\/\/doi.org\/10.1097\/DCR.0000000000000149","journal-title":"Dis Colon Rectum"},{"key":"2839_CR35","doi-asserted-by":"publisher","first-page":"99","DOI":"10.3978\/j.issn.2078-6891.2015.100","volume":"7","author":"AD Newton","year":"2016","unstructured":"Newton AD, Bartlett EK, Karakousis GC (2016) Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy: a review of factors contributing to morbidity and mortality. J Gastrointest Oncol 7:99\u2013111. https:\/\/doi.org\/10.3978\/j.issn.2078-6891.2015.100","journal-title":"J Gastrointest Oncol"},{"key":"2839_CR36","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1016\/j.ejso.2018.10.545","volume":"45","author":"A Oemrawsingh","year":"2019","unstructured":"Oemrawsingh A, de Boer NL, Brandt-Kerkhof ARM et al (2019) Short-term complications in elderly patients undergoing CRS and HIPEC: a single center\u2019s initial experience. Eur J Surg Oncol 45:383\u2013388. https:\/\/doi.org\/10.1016\/j.ejso.2018.10.545","journal-title":"Eur J Surg Oncol"},{"key":"2839_CR37","doi-asserted-by":"publisher","first-page":"811","DOI":"10.1007\/s40520-022-02121-z","volume":"34","author":"L Marano","year":"2022","unstructured":"Marano L, Carbone L, Poto GE et al (2022) Handgrip strength predicts length of hospital stay in an abdominal surgical setting: the role of frailty beyond age. Aging Clin Exp Res 34:811\u2013817. https:\/\/doi.org\/10.1007\/s40520-022-02121-z","journal-title":"Aging Clin Exp Res"},{"key":"2839_CR38","doi-asserted-by":"publisher","first-page":"1762","DOI":"10.1007\/s00464-015-4440-2","volume":"30","author":"M Tahiri","year":"2016","unstructured":"Tahiri M, Sikder T, Maimon G et al (2016) The impact of postoperative complications on the recovery of elderly surgical patients. Surg Endosc 30:1762\u20131770. https:\/\/doi.org\/10.1007\/s00464-015-4440-2","journal-title":"Surg Endosc"},{"key":"2839_CR39","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1001\/jamasurg.2020.0091","volume":"155","author":"VL Tang","year":"2020","unstructured":"Tang VL, Jing B, Boscardin J et al (2020) Association of functional, cognitive, and psychological measures with 1-year mortality in patients undergoing major surgery. JAMA Surg 155:412. https:\/\/doi.org\/10.1001\/jamasurg.2020.0091","journal-title":"JAMA Surg"},{"key":"2839_CR40","doi-asserted-by":"publisher","DOI":"10.3390\/cancers14235824","volume":"14","author":"F Carboni","year":"2022","unstructured":"Carboni F, Valle M, Vaira M et al (2022) Complications and mortality rate of cytoreductive surgery with hyperthermic intraperitoneal chemotherapy: Italian peritoneal surface malignancies oncoteam results analysis. Cancers (Basel) 14:5824. https:\/\/doi.org\/10.3390\/cancers14235824","journal-title":"Cancers (Basel)"},{"key":"2839_CR41","doi-asserted-by":"publisher","first-page":"2449","DOI":"10.1200\/JCO.2011.39.7166","volume":"30","author":"TC Chua","year":"2012","unstructured":"Chua TC, Moran BJ, Sugarbaker PH et al (2012) Early- and long-term outcome data of patients with pseudomyxoma peritonei from appendiceal origin treated by a strategy of cytoreductive surgery and hyperthermic intraperitoneal chemotherapy. J Clin Oncol 30:2449\u20132456. https:\/\/doi.org\/10.1200\/JCO.2011.39.7166","journal-title":"J Clin Oncol"},{"key":"2839_CR42","doi-asserted-by":"publisher","first-page":"2958","DOI":"10.1245\/s10434-015-4387-5","volume":"22","author":"D Go\u00e9r\u00e9","year":"2015","unstructured":"Go\u00e9r\u00e9 D, Souadka A, Faron M et al (2015) Extent of colorectal peritoneal carcinomatosis: attempt to define a threshold above which HIPEC does not offer survival benefit: a comparative study. Ann Surg Oncol 22:2958\u20132964. https:\/\/doi.org\/10.1245\/s10434-015-4387-5","journal-title":"Ann Surg Oncol"},{"key":"2839_CR43","doi-asserted-by":"publisher","first-page":"527","DOI":"10.1007\/s00423-019-01805-x","volume":"404","author":"V Narasimhan","year":"2019","unstructured":"Narasimhan V, Das A, Warrier S et al (2019) Evaluation of cytoreductive surgery and HIPEC for peritoneal surface malignancies: analysis of 384 consecutive cases. Langenbecks Arch Surg 404:527\u2013539. https:\/\/doi.org\/10.1007\/s00423-019-01805-x","journal-title":"Langenbecks Arch Surg"},{"key":"2839_CR44","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1016\/j.ygyno.2009.03.004","volume":"113","author":"A Fagotti","year":"2009","unstructured":"Fagotti A, Paris I, Grimolizzi F et al (2009) Secondary cytoreduction plus oxaliplatin-based HIPEC in platinum-sensitive recurrent ovarian cancer patients: a pilot study. Gynecol Oncol 113:335\u2013340. https:\/\/doi.org\/10.1016\/j.ygyno.2009.03.004","journal-title":"Gynecol Oncol"},{"key":"2839_CR45","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2020.13940","volume":"3","author":"Z Lei","year":"2020","unstructured":"Lei Z, Wang Y, Wang J et al (2020) Evaluation of cytoreductive surgery with or without hyperthermic intraperitoneal chemotherapy for stage III epithelial ovarian cancer. JAMA Netw Open 3:e2013940. https:\/\/doi.org\/10.1001\/jamanetworkopen.2020.13940","journal-title":"JAMA Netw Open"},{"key":"2839_CR46","doi-asserted-by":"publisher","first-page":"2617","DOI":"10.1245\/s10434-021-11087-7","volume":"29","author":"CCP Antonio","year":"2022","unstructured":"Antonio CCP, Alida GG, Elena GG et al (2022) Cytoreductive surgery with or without HIPEC after neoadjuvant chemotherapy in ovarian cancer: a phase 3 clinical trial. Ann Surg Oncol 29:2617\u20132625. https:\/\/doi.org\/10.1245\/s10434-021-11087-7","journal-title":"Ann Surg Oncol"},{"key":"2839_CR47","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1245\/s10434-021-10376-5","volume":"29","author":"LF Liesenfeld","year":"2022","unstructured":"Liesenfeld LF, Wagner B, Hillebrecht HC et al (2022) HIPEC-induced acute kidney injury: a retrospective clinical study and preclinical model. Ann Surg Oncol 29:139\u2013151. https:\/\/doi.org\/10.1245\/s10434-021-10376-5","journal-title":"Ann Surg Oncol"},{"key":"2839_CR48","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1006\/scbi.2001.0399","volume":"12","author":"NP Restifo","year":"2002","unstructured":"Restifo NP, Antony PA, Finkelstein SE et al (2002) Assumptions of the tumor \u2018escape\u2019 hypothesis. Semin Cancer Biol 12:81\u201386. https:\/\/doi.org\/10.1006\/scbi.2001.0399","journal-title":"Semin Cancer Biol"},{"key":"2839_CR49","doi-asserted-by":"publisher","first-page":"783","DOI":"10.1245\/s10434-019-07964-x","volume":"27","author":"JT Wiseman","year":"2020","unstructured":"Wiseman JT, Kimbrough C, Beal EW et al (2020) Predictors of anastomotic failure after cytoreductive surgery and hyperthermic intraperitoneal chemotherapy: does technique matter? Ann Surg Oncol 27:783\u2013792. https:\/\/doi.org\/10.1245\/s10434-019-07964-x","journal-title":"Ann Surg Oncol"},{"key":"2839_CR50","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1097\/DCR.0b013e31826f2672","volume":"56","author":"K Mrak","year":"2013","unstructured":"Mrak K, Eberl T, Laske A et al (2013) Impact of postoperative complications on long-term survival after resection for rectal cancer. Dis Colon Rectum 56:20\u201328. https:\/\/doi.org\/10.1097\/DCR.0b013e31826f2672","journal-title":"Dis Colon Rectum"}],"container-title":["Updates in Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13304-026-02839-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s13304-026-02839-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13304-026-02839-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T12:18:32Z","timestamp":1789129112000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s13304-026-02839-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,11]]},"references-count":50,"alternative-id":["2839"],"URL":"https:\/\/doi.org\/10.1007\/s13304-026-02839-9","relation":{},"ISSN":["2038-131X","2038-3312"],"issn-type":[{"value":"2038-131X","type":"print"},{"value":"2038-3312","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,11]]},"assertion":[{"value":"4 March 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 August 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 September 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors have no financial or proprietary interests in any material discussed in this article. An author serves on the journal\u2019s Editorial Board.","order":1,"name":"Ethics","label":"Conflict of interest","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was conducted in accordance with the tenets of the Declaration of Helsinki. Patient confidentiality and data protection were ensured throughout the study by anonymizing patient information and using secure electronic databases. All patients provided written informed consent before participating in the study and the Internal Review Board (IRB) approved the collection of data (HYPO-TOSCANA vers. 1, Nov 13, 2023; COMPLI-HIPEC vers. 2, May 09, 2024).","order":2,"name":"Ethics","label":"Ethical approval","group":{"name":"EthicsHeading","label":"Declarations"}}]}}